MENU
SYRS
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Syros Pharmaceuticals (SYRS) Ownership - Who owns Syros Pharmaceuticals?
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
670.81K
P/E Ratio
N/A
Total Cash
165.98M
Projected Growth
N/A
Total Debt
60.23M
Revenue
386K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.19
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
SYRS
Capitalization
N/A
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
N/A
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a therapeutics company focusing on discovering and developing novel gene control therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A